Resumen El síndrome de Hughes Stovin es una vasculitis de pequeños y grandes vasos, más frecuente en hombres jóvenes. Se manifiesta con trombosis y aneurismas. Inicia con tromboflebitis que evoluciona a aneurismas con eventual desenlace fatal por ruptura de los mismos. Algunos autores consideran el síndrome de Hughes Stovin como una variante de la enfermedad de Behçet. El diagnóstico es clínico y el tratamiento de primera línea son los corticoides y la ciclofosfamida. Frente a un caso de trombosis, la anticoagulación es controversial por el riesgo de sangrado. Presentamos el caso de un varón joven con cuadro clínico compatible en el cual se descartaron otras patologías con requerimiento de tratamiento quirúrgico por mala evolución clínica.

Abstract Hughes Stovin syndrome is characterized by small and big vessels vasculitis, more commonly presented in young men. Initially it manifests with thrombophlebitis and aneurysms which can cause fatal bleed due to rupture. Some authors consider Hughes Stovin syndrome as a variant of Behcet's disease. Diagnosis is made by clinical findings and the first line treatment are corticosteroids and cyclophosphamide. Anticoagulation is controversial due to the increased risk of hemorrhage.

RESUMO RACIONAL: A pandemia de COVID-19 teve um efeito negativo na educação cirúrgica na América Latina, diminuindo o treinamento cirúrgico dos residentes e a prática clínica supervisionada. OBJETIVOS: Identificar estratégias que foram propostas ou implementadas para adaptar o treinamento cirúrgico e a prática clínica supervisionada às limitações relacionadas ao COVID-19 na América Latina. MÉTODOS: Foi realizada revisão de literatura entre abril-maio de 2021, dividida em duas buscas. O primeiro procurou identificar estratégias de adaptação em América Latina para treinamento cirúrgico e prática clínica supervisionada. A segunda foi realizada como complemento para identificar metodologias propostas no resto do mundo. RESULTADOS: Na primeira busca, foram selecionados 16 dos 715 artigos. Na segunda, foram selecionados 41 dos 1.637 artigos. Estratégias adaptativas propostas na América Latina com foco em videoconferência e simulação. No resto do mundo, foram sugeridas análises críticas remotas de cirurgias gravadas/ao vivo, tele-mentoria intra-cirúrgica e gravação de cirurgia com feedback pós-operatório. CONCLUSÕES: Múltiplas estratégias de adaptação para educação cirúrgica durante a pandemia de COVID-19 foram propostas na América Latina e no resto do mundo. Há uma oportunidade de implementar novas estratégias a longo prazo para treinamento cirúrgico e prática clínica supervisionada, embora mais estudos prospectivos sejam necessários para gerar recomendações baseadas em evidências.

ABSTRACT BACKGROUND: The COVID-19 pandemic has had a negative effect on surgical education in Latin America, decreasing residents’ surgical training and supervised clinical practice. AIMS: This study aimed to identify strategies that have been proposed or implemented to adapt surgical training and supervised clinical practice to COVID-19-related limitations in Latin America. METHOD: A literature review was performed between April and May 2021, divided into two searches. The first one sought to identify adaptation strategies in Latin America for surgical training and supervised clinical practice. The second one was carried out as a complement to identify methodologies proposed in the rest of the world. RESULTS: In the first search, 16 of 715 articles were selected. In the second one, 41 of 1,637 articles were selected. Adaptive strategies proposed in Latin America focused on videoconferencing and simulation. In the rest of the world, remote critical analysis of recorded/live surgeries, intrasurgical tele-mentoring, and surgery recording with postoperative feedback were suggested. CONCLUSIONS: Multiple adaptation strategies for surgical education during the COVID-19 pandemic have been proposed in Latin America and the rest of the world. There is an opportunity to implement new strategies in the long term for surgical training and supervised clinical practice, although more prospective studies are required to generate evidence-based recommendations.

ABSTRACT Introduction: Endoleak is the main cause for reintervention after endovascular aortic repair. Some patientis need prolonged oral anticoagulation, which may increase the incidence of postoperative endoleaks. Objectives: Our objective was to determine whether postoperative oral anticoagulation has an impact on the incidence of endoleaks. Methods: This retrospective analysis included all patientis with endovascular treatment of abdominal aortic aneurysm at our center between 2009 and 2014. Two groups of patientis were determined according to the need for oral anticoagulation. Aortic-related mortality, survival free from reinterventions, any endoleak and non-type II endoleaks, survival free of the composite endpoint of mortality associated with the aorta, reinterventions and endoleaks, and reduction of aneurysmal sac diameter was compared between both groups.Resultis: Among 341 treated patientis, 33 (9.67%) were anticoagulated. There were no differences between the two groups in terms of aorta-related mortality (2.59% vs. 3.03%, p=ns), reintervention-free survival (84.04% vs. 86.2%; p=ns), any endoleak- free survival (82% vs. 89%, p=0.81) or non-type II endoleak-free survival (88% vs. 88%, p=0.52). Similarly, no significant differences were found when analyzing the composite endpoint-free survival (80% vs. 85%, p=ns). The average reduction of aneurysmal sac diameter was 5.19 mm and 3.51 mm (p=0.2). Conclusions: No difference was registered in any of the resultis analyzed. Postoperative oral anticoagulation had no impact on the resultis of endovascular aortic treatment.

RESUMEN Introducción: La endofuga es la principal causa de reintervención después del tratamiento endovascular de aorta. Algunos pacientes necesitan anticoagulación oral prolongada, lo cual puede aumentar la incidencia de endofugas posoperatorias. Objetivos: Nuestro objetivo es determinar si la anticoagulación oral posoperatoria tiene impacto en la incidencia de endofugas. Material y métodos: Este análisis retrospectivo incluyó todos los pacientes con aneurisma de aorta abdominal tratados por vía endovascular entre 2009 y 2014 en nuestro centro. Se determinaron dos grupos de pacientes de acuerdo con la necesidad de anticoagulación oral y se comparó entre ambos grupos la mortalidad relacionada con la aorta; la supervivencia libre de reintervenciones, de cualquier endofuga y de endofugas no tipo II; supervivencia libre de un punto final compuesto por mortalidad relacionada con la aorta, reintervenciones y endofugas, y la reducción del diámetro del saco aneurismático. Resultados: De 341 pacientes tratados, 33 (9,67%) estaban anticoagulados. No hubo diferencias entre ambos grupos en términos de mortalidad relacionada con la aorta (2,59% vs. 3,03%, p = ns), supervivencia libre de reintervenciones (84,04% vs. 86,2%; p = ns), supervivencia libre de cualquier endofuga (82% vs. 89%; p = 0,81) o supervivencia libre de endofugas no tipo II (88% vs. 88%; p = 0,52). Al analizar la supervivencia libre del punto final compuesto tampoco se encontraron diferencias significativas (80% vs. 85%; p = ns). La reducción promedio del diámetro del saco aneurismático fue de 5,19 mm y 3,51 mm (p = 0,2). Conclusiones: No se registró diferencia en ninguno de los resultados analizados. La anticoagulación oral posoperatoria no tuvo impacto en los resultados del tratamiento endovascular de aorta.